Rodriguez, M A <br/><br/>
Factors that influence prognosis of intermediate-grade lymphomas at relapse.  [electronic resource] 

 -  Cancer treatment and research  1996 
 - 79-86 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0927-3042 
<br/><br/><label>Standard No.: </label>10.1007/978-1-4615-4129-5_6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cisplatin--therapeutic use<br/>Cytarabine--therapeutic use<br/>Etoposide--therapeutic use<br/>Humans<br/>Ifosfamide--therapeutic use<br/>L-Lactate Dehydrogenase--blood<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Mesna--therapeutic use<br/>Methylprednisolone--therapeutic use<br/>Middle Aged<br/>Mitoxantrone--therapeutic use<br/>Outcome Assessment, Health Care<br/>Prognosis<br/>beta 2-Microglobulin--analysis